BMY250110C55000
- 1.28
- -1.00-43.86%
Bristol-Myers Squibb Newsroom
Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Salesforce To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Truist Raises Price Target on Bristol-Myers Squibb to $65 From $62, Keeps Buy Rating
Bristol-Myers Squibb Analyst Ratings
Truist Financial Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Announces Target Price $65
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Bristol Late-stage Trial of Opdivo for Head and Neck Cancer Meets Endpoint
Express News | Refile-Buzz-Obesity Drugs, M&a Among Key Pharma Drivers for 2025, Berenberg Says
Should Bristol-Myers Squibb Company (NYSE:BMY) Be In Your Early Retirement Portfolio?
Bristol-Myers Squibb (NYSE:BMY) Has A Pretty Healthy Balance Sheet
Express News | Bristol-Myers Squibb Co -Preliminary Estimated Q4 Impact of Acquired in-Process Research and Development and Licensing Loss of $18 Mln
Market Climbed Monday Just Past Santa Rally High Water Mark | Wall Street Today
FDA Issues First Draft Guidance on Use of AI in Drug, Medical Device Development
CES Tech Conference Week Starts with Nvidia and Chips Climbing | Live Stock
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Santa Claus Came Without Rallying the Troops | Live Stock